HES1 and breast carcinoma: Furthermore, additional research suggested that lutein could be a promising candidate for breast cancer chemoprevention, with HES1 potentially playing a crucial role in mediating lutein’s suppression of hypoxia-induced, ROS-driven breast cancer progression (Li et al. 2018).